Cumberland Pharmaceuticals (CPIX) Institutional Ownership → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free CPIX Stock Alerts $1.48 +0.03 (+2.07%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cumberland Pharmaceuticals (NASDAQ:CPIX)CurrentInstitutional OwnershipPercentage15.51%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$274.99KNumber ofInstitutional Sellers(last 12 months)0 Get CPIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cumberland Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CPIX Institutional Buying and Selling by Quarter Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. Cumberland Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/24/2023 Bank of New York Mellon Corp75,268$142K0.0%N/A0.524% 7/27/2023 B. Riley Wealth Advisors Inc.90,298$133K0.0%N/A0.625% 2/10/2023True Capital Management12,025$27K0.0%N/A0.082% 5/24/2022 M Holdings Securities Inc.10,750$30K0.0%N/A0.073% 2/10/2022 Acadian Asset Management LLC147,294$683K0.0%-9.2%0.995% 2/9/2022 Dimensional Fund Advisors LP652,561$3.05M0.0%-6.3%4.406% Get the Latest News and Ratings for CPIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2021 Berkshire Asset Management LLC PA176,185$472K0.0%+3.1%1.184% 11/15/2021 Dimensional Fund Advisors LP696,654$1.88M0.0%-7.8%4.682% 11/12/2021 Renaissance Technologies LLC664,564$1.78M0.0%-5.3%4.466% 11/9/2021 BlackRock Inc.333,051$892K0.0%-15.9%2.238% 8/17/2021 Berkshire Asset Management LLC PA170,830$486K0.0%+3.2%1.135% 8/13/2021 Renaissance Technologies LLC701,463$2.00M0.0%-6.9%4.661% 8/13/2021 California Public Employees Retirement System10,205$29K0.0%-79.3%0.068% 8/13/2021 Ariel Investments LLC12,033$34K0.0%-94.3%0.080% 8/12/2021 Dimensional Fund Advisors LP755,500$2.15M0.0%+2.4%5.020% 5/21/2021 Citadel Advisors LLC17,005$52K0.0%N/A0.113% 5/18/2021 Citadel Advisors LLC17,005$52K0.0%N/A0.114% 5/14/2021 Arrowstreet Capital Limited Partnership10,700$32K0.0%N/A0.072% 5/14/2021 Dimensional Fund Advisors LP737,881$2.24M0.0%-5.6%4.945% 5/13/2021 Renaissance Technologies LLC753,053$2.28M0.0%+11.5%5.047% 5/12/2021 M Holdings Securities Inc.10,750$33K0.0%N/A0.072% 5/11/2021 Acadian Asset Management LLC175,015$529K0.0%+66.7%1.173% 3/8/2021 Dimensional Fund Advisors LP781,891$2.30M0.0%-2.1%5.207% 2/25/2021 Dimensional Fund Advisors LP781,891$2.30M0.0%-2.1%5.207% 2/12/2021 Stonepine Capital Management LLC188,703$557K0.4%-68.0%1.257% 2/12/2021 Ariel Investments LLC821,096$2.42M0.0%+4.9%5.468% 2/10/2021 Renaissance Technologies LLC675,159$1.99M0.0%+12.6%4.496% 2/10/2021 Sterling Financial Planning Inc.22,031$65K0.1%N/A0.147% 11/13/2020 Stonepine Capital Management LLC589,497$1.89M2.0%-12.9%3.894% 11/6/2020 BlackRock Inc.364,974$1.17M0.0%+2.1%2.411% 7/16/2020 Wedbush Securities Inc.13,041$43K0.0%N/A0.086% 5/15/2020 Morgan Stanley12,168$44K0.0%-20.5%0.080% 5/14/2020 Stonepine Capital Management LLC907,735$3.30M3.5%+1.3%5.979% 5/11/2020 Acadian Asset Management LLC92,643$335K0.0%-5.7%0.610% 5/1/2020 BlackRock Inc.327,615$1.19M0.0%-1.2%2.158% (Data available from 1/1/2016 forward) CPIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CPIX shares? During the previous two years, the following institutional investors and hedge funds held shares of Cumberland Pharmaceuticals shares: Bank of New York Mellon Corp ($142K), and B. Riley Wealth Advisors Inc. ($133K), True Capital Management ($27K).Learn more on CPIX's institutional investors. What percentage of Cumberland Pharmaceuticals stock is owned by institutional investors? 15.51% of Cumberland Pharmaceuticals stock is owned by institutional investors. Learn more on CPIX's institutional investor holdings. Which institutional investors have been buying Cumberland Pharmaceuticals stock? The following institutional investors have purchased Cumberland Pharmaceuticals stock in the last 24 months: B. Riley Wealth Advisors Inc. ($90.30K), Bank of New York Mellon Corp ($75.27K), and True Capital Management ($12.03K). How much institutional buying is happening at Cumberland Pharmaceuticals? Institutional investors have bought a total of 177,591 shares in the last 24 months. This purchase volume represents approximately $302.05K in transactions. Related Companies: ITRM Major Shareholders BFRG Major Shareholders BCTX Major Shareholders UBX Major Shareholders SLGL Major Shareholders LSTA Major Shareholders FBRX Major Shareholders BIOR Major Shareholders MEIP Major Shareholders ONCT Major Shareholders This page (NASDAQ:CPIX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
